BREAKING NEWS: Trump to Nominate Robert F. Kennedy Jr. as HHS Secretary
Controversial figure Robert F. Kennedy has been announced as Trump’s HHS Secretary nominee
Read More
PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly Into the Brain
The PTC Therapeutics gene therapy, Kebilidi, treats an enzyme deficiency that affects the body’s ability to produce dopamine, a neurotransmitter important for motor control. FDA approval for the product comes two years after it won its first regulatory approvals in Europe. The post PTC Therapeutics Wins First FDA Approval for a Gene Therapy Dosed Directly…
Video: What Would Happen If Prior Authorization Went Away?
Prior authorization is a sore subject for payers and providers. So what if it went away? In a recent fireside chat hosted by MedCity News, Don Antonucci, CEO of Providence Health Plan, shared his thoughts. The post Video: What Would Happen If Prior Authorization Went Away? appeared first on MedCity News.
CEO of Otsuka North America: Are We Getting better access with AI?
In an interview, Rabah talked about the promise of AI, where it can have the most impact, while also responding to the IRA and high drug prices in the United States. The post CEO of Otsuka North America: Are We Getting better access with AI? appeared first on MedCity News.
AHA Urges Congress to Act on Key Priorities
Headed into a lame-duck session, the AHA requested Congress to act on key priorities for health systems before the end of 2024
Five Building Blocks to a Resilient Healthcare Cybersecurity Culture
By Edward Myers, National Director of Cyber Security, Crothall Healthcare Technology Solutions (HTS) US hospitals are stepping up their defenses against cybersecurity attacks.Much of the focus on recent cyber spending is in response to the February 2024 hack of payments manager Change Healthcare. A whopping 94 percent of American Hospital Association members reported suffering a…
KFF Health News’ ‘What the Health?’: Readying for Republican Rule
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Will AI help patients appeal insurance denials?
It looks like the answer is ‘yes’. KFF reports that Holden Karau, a software engineer from the San Francisco Bay Area, created an AI tool to help appeal insurance denials. She calls it: Fight Health Insurance, How does it work? You’ve gotta make a scan of the denial letter from your insurance company, and run…
THCB Gang Episode 14, Friday November 14
Joining Matthew Holt (@boltyboy) on #THCBGang on Thursday November 14 at 1PM PT 4PM ET. Today we have also a special guest – former Permanente Medical Group CEO Dr Robbie Pearl @robertpearlmd. Robbie has been diving into AI in his latest book ChatGPT-MD and we’ll be chatting about that as well as his forecasts for health…
Merck Is Paying $588M for Potential Successor to Cancer Drug Juggernaut Keytruda
Merck is acquiring global rights to a bispecific antibody from LaNova Medicines that blocks two cancer targets, PD-1 and VEGF. The deal comes one day after BioNTech announced an $800 million acquisition that gives it full rights to a molecule in this hot class of cancer drug candidates. The post Merck Is Paying $588M for…